Latest News

UBS downgrades Quest Diagnostics, sees company at risk of missing earnings targets

46 views0
By
Share

UBS said Quest’s 2023 earnings guidance may be too aggressive given the company’s rising costs.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
Previous
Next

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News